Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods to reduce beta-agonist-mediated tachyphylaxis

Compositions and methods to reduce beta-agonist-mediated tachyphylaxis

US Patent 10927375 · Granted Feb 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bronchodilators for treating obstructive lung disease2025
Biased adrenergic agonists2024
Inhibition of beta-arrestin oligomerization in tauopathy2024
Methods of treating obstructive lung diseases using bitter tastants2017
Methods for treatment with bucindolol based on genetic targeting2014
G-protein coupled receptor kinase-5 polymorphism2013
Methods for treatment with bucindolol based on genetic targeting2012
Methods for treatment with bucindolol based on genetic targeting2011
Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclas2011
Methods for treatment with bucindolol based on genetic targeting2010
Heart failure assessment based on alpha-2C adrenergic receptor polymorphisms2010
Alpha-2 adrenergic receptor polymorphisms2009